A Computational Approach to Identify Interfering Medications on Urine Drug Screening Assays without Data from Confirmatory Testing.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
12 Apr 2021
Historique:
received: 25 09 2020
revised: 29 07 2020
accepted: 25 09 2020
pubmed: 30 9 2020
medline: 28 4 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Urine drug screening (UDS) assays can rapidly and sensitively detect drugs of abuse but can also produce spurious results due to interfering substances. We previously developed an approach to identify interfering medications using electronic health record (EHR) data, but the approach was limited to UDS assays for which presumptive positives were confirmed using more specific methods. Here we adapted the approach to search for medications that cause false positives on UDS assays lacking confirmation data. From our institution's EHR data, we used our previous dataset of 698,651 UDS and confirmation results. We also collected 211,108 UDS results for acetaminophen, ethanol and salicylates. Both datasets included individuals' prior medication exposures. We hypothesized that the odds of a presumptive positive would increase following exposure to an interfering medication independently of exposure to the assay's target drug(s). For a given assay-medication pair, we quantified potential interference as an odds ratio from logistic regression. We evaluated interference of selected compounds in spiking experiments. Compared to the approach requiring confirmation data, our adapted approach showed only modestly diminished ability to detect interfering medications. Applying our approach to the new data, we discovered and validated multiple compounds that can cause presumptive positives on the UDS assay for acetaminophen. Our approach can reveal interfering medications using EHR data from institutions at which UDS results are not routinely confirmed.

Identifiants

pubmed: 32991692
pii: 5912960
doi: 10.1093/jat/bkaa140
pmc: PMC8040373
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-330

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002243
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

J Biomed Inform. 2014 Dec;52:28-35
pubmed: 24534443
J Am Med Inform Assoc. 2011 Jul-Aug;18(4):441-8
pubmed: 21515544
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
Biostatistics. 2017 Apr 1;18(2):275-294
pubmed: 27756721
Clin Chem. 2019 Dec;65(12):1522-1531
pubmed: 31578215
J Anal Toxicol. 2014 Sep;38(7):387-96
pubmed: 24986836

Auteurs

Nadia Ayala-Lopez (N)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37203, USA.

Layla Aref (L)

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, USA.

Jennifer M Colby (JM)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37203, USA.

Jacob J Hughey (JJ)

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH